Table 1.
Patient and treatment characteristics (330 patients with 623 tumours).
| Characteristic | No. (%) or Median (Range) |
|---|---|
| Sex | |
| Males Females |
205 (62%) 125 (38%) |
| Age (years) | 76 (23–98) |
| No. tumours/patient | 1 (1–7) |
| Tumour presentation | |
| Primary naïve Primary persistent Recurrent |
200 (61%) 79 (24%) 51 (15%) |
| Tumour size (mm) | 13 (5–350) |
| ≤3 cm >3 cm |
560 (90%) 63 (10%) |
| Anatomical location | |
| Head and Neck Trunk Limbs |
496 (80%) 74 (12%) 53 (8%) |
| Previous treatment | |
| None Surgical excision Other a Unknown |
200 (61%) 116 (35%) 12 (3%) 2 (1%) |
| Anaesthesia | |
| Local Local + sedation |
223 (68%) 107 (32%) |
| BLM administration | |
| Intratumoural Intravenous |
146 (44%) 184 (56%) |
| Electrode geometry | |
| Row needle Hexagonal needle Plate Combination |
383 (61.5%) 164 (26.3%) 44 (7.1%) 23 (5.1%) |
| Retreatment (No. of pts) Interval to 2nd ECT (months) |
52 (16%) 6.7 (1.2–47) |
a radiotherapy, n = 4; cryotherapy, n = 2; photodynamic therapy, n = 2; topical therapies, n = 3; ECT, n = 1.